Guinn 2000.
Methods | RCT. Computer‐generated sequence. Opaque, sealed, sequentially numbered envelopes. | |
Participants | Singleton, vertex presentation, intact membranes. Unfavourable cervix (< 2 cm dilated and effacement < 75%). Exclusion: bleeding, labour, asthma. prior vertical uterine incision, acute fetal compromise | |
Interventions | Laminaria and IV oxytocin: as many laminaria as possible were kept for 12 hours, unless expelled or membranes ruptured. IV oxytocin was simultaneously given (165 women); EASI + IV oxytocin: Foley catheter balloon filled with 30 mL of water followed by saline infusion 30 mL/hour. IV oxytocin was simultaneously given (169 women); PGE2 intracervical gel 0.5 mg/6H, max 2 doses. IV oxytocin was started if not in labour after 2 doses of PGE2 (110 women). | |
Outcomes | CS, delay to delivery, delivery within 24 hours, infections, haemorrhage. | |
Notes | After interim analysis, the authors stopped recruiting in the PGE2 group. 68 protocol violations, but ITT analysis was conducted. Setting: University of Alabama and Cooper Green Hospitals Birmingham, Alabama Dates of study: January 1994 to August 1997 Funding sources: UpJohn Pharmaceuticals provided funds to purchase study drugs Declarations of interest: not reported |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Computer‐generated random number table |
Allocation concealment (selection bias) | Low risk | Opaque sealed envelopes |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Not feasible due to nature of intervention |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not reported |
Incomplete outcome data (attrition bias) All outcomes | Low risk | ITT |
Selective reporting (reporting bias) | Unclear risk | All pre‐specified outcomes reported for laminaria and EASI |
Other bias | Unclear risk | After interim analysis, the authors stopped recruiting in the PGE2 group. |